Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252211943 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Enrique Vazquez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology 1/Neurophysiology, Jena University Hospital, Friedrich-Schiller-University, D-07740 Jena, Germany. Hauptthemen laut MEDLINE: Azetidines, Sulfonamides, Purines, Pyrazoles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Therapeutically, the Janus kinase (Jak) 1/Jak2 inhibitor baricitinib reduces the pathology of rheumatoid arthritis and may also reduce pain. Here, we investigated whether baricitinib directly affects joint nociceptors. We recorded action potentials from nociceptive C- and A∂-fibers of the normal and inflamed knee joint in anesthetized rats to monitor their responses to innocuous and noxious joint rotation. In isolated and cultured dorsal root ganglion (DRG) neurons, we examined Stat3 activation using Western blots and monitored excitability using patch-clamp recordings. Intra-articular injection of baricitinib did not alter C- and A∂-fiber responses to innocuous and noxious rotations of the normal knee but reduced C-fiber responses to these stimuli in inflamed joints. Baricitinib prevented the increase in C-fiber responses to joint rotation evoked by interleukin (IL)-6 plus soluble interleukin-6 receptor (sIL-6R) but not the increase evoked by TNF. In DRG neurons, baricitinib blocked Stat3 activation by hyper-IL-6, and baricitinib or the Stat3 inhibitor Sta21 prevented induction of hyperexcitability by IL-6 plus sIL-6R. Thus, neuronal Jaks are involved in the generation of C-fiber hyperexcitability induced by inflammation and IL-6. Pain reduction by baricitinib may result, at least in part, from direct effects on joint nociceptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Physiology 1/Neurophysiology, Jena University Hospital, Friedrich-Schiller-University, D-07740 Jena, Germany.
- Department of Trauma, Hand and Reconstructive Surgery, Experimental Trauma Surgery, Jena University Hospital, Friedrich-Schiller-University, D-07740 Jena, Germany.
ORCID-Profile: Enrique Vazquez, Gabriel Natura, Christian König, Annett Eitner, Hans-Georg Schaible
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Vazquez, E., Richter, F., Natura, G., König, C., Eitner, A., & Schaible, H. G. (2024). Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211943
Vancouver
Vazquez E, Richter F, Natura G, König C, Eitner A, Schaible HG. Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211943
BibTeX
@article{Vazquez2024,
author = {Vazquez, Enrique and Richter, Frank and Natura, Gabriel and König, Christian and Eitner, Annett and Schaible, Hans-Georg},
title = {Direct Effects of the Janus Kinase Inhibitor Baricitinib on Sensory Neurons},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252211943}
}
EUVIMED